The litigation, filed under the Securities Exchange Act of 1934, targets the company’s financial reporting between February 28, 2024, and February 25, 2026. According to the complaint, these practices rendered public statements regarding the firm's financial health materially misleading. Investors who purchased PRCT shares during this window are now being represented by the DJS Law Group as they seek to recover losses.
In section Releases
Investors File Securities Class Action Against PROCEPT BioRobotics
A federal class action lawsuit alleges that PROCEPT BioRobotics Corporation misled shareholders by artificially inflating revenue figures. The complaint centers on claims that the company utilized aggressive discounting tactics to pull future sales into current periods, resulting in an undisclosed glut of inventory throughout the class period.
The deadline for shareholders to petition the court for appointment as lead plaintiff is September 22, 2026. While the firm, led by David J. Schwartz, is actively recruiting participants to bolster the case, stakeholders are reminded that serving as a lead plaintiff is not a prerequisite for participating in any potential financial recovery resulting from the litigation.
Comments (0)
No comments yet. Be the first!